The bitter pill. Pt. 3, Malaria in Malawi.

In Malawi, the mosquito brings fever and death. Malaria affects 300m people p.a. and kills 1m., mostly in Africa, so why are no new drugs being developed? Drugs, like chloroquin, were developed when govts sought to protect troops from disease during war, but now, without a wealthy military customer, drug companies are not motivated to research new drugs. In Malawi, 10% of the budget is spent on treating malaria, but this does not fund new research. This programme considers how companies could be forced (or persuaded) to develop drugs for poor countries, forced to be more ethical? Could they adopt 'fair pricing' in relation to earnings, a stronger patent system, or a system of tax credits for companies developing drugs for the poor?